|
Tabla 5: Proporciones agrupadas de resistencia a los antibióticos para Pseudomonas aeruginosa. |
||||||
|
Resistencia % |
General N = 621 n (%) |
2020 N = 111 n (%) |
2021 N = 125 n (%) |
2022 N = 179 n (%) |
2023 N = 152 n (%) |
2024 N = 54 n (%) |
|
Ciprofloxacino |
305 (49.1) |
54 (48.6) |
65 (52.0) |
83 (46.4) |
72 (47.4) |
31 (57.4) |
|
Gentamicina |
196 (31.6) |
35 (31.5) |
45 (36.0) |
52 (29.1) |
44 (28.9) |
20 (37.0) |
|
Levofloxacino |
488 (78.6) |
87 (78.4) |
106 (84.8) |
139 (77.7) |
113 (74.3) |
43 (79.6) |
|
Piperacilina- tazobactam |
308 (49.6) |
60 (54.1) |
69 (55.2) |
83 (46.4) |
70 (46.1) |
26 (48.1) |
|
Cefepima |
222 (35.7) |
46 (41.4) |
66 (52.8) |
40 (22.3) |
50 (32.9) |
20 (37.0) |
|
Imipenem |
165 (26.6) |
32 (28.8) |
33 (26.4) |
40 (22.3) |
41 (27.0) |
19 (35.2) |
|
Meropenem |
143 (23.0) |
18 (16.2) |
32 (25.6) |
46 (25.7) |
34 (22.4) |
13 (24.1) |
|
Tobramicina |
603 (97.1) |
109 (98.2) |
123 (98.4) |
171 (95.5) |
147 (96.7) |
53 (98.1) |
|
Ceftazidima |
192 (30.9) |
35 (31.5) |
51 (40.8) |
49 (27.4) |
37 (24.3) |
20 (37.0) |